Evidence map›Paper›PMID 36589243›Full record

ArticleFrontiers in molecular biosciences2022

Crystal polymorphism in fragment-based lead discovery of ligands of the catalytic domain of UGGT, the glycoprotein folding quality control checkpoint.

Alessandro T Caputo, Roberta Ibba, James D Le Cornu, Benoit Darlot, Mario Hensen, Colette B Lipp, Gabriele Marcianò, Snežana Vasiljević, Nicole Zitzmann, Pietro Roversi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Alessandro T CaputoBiochemistry Department, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom.
Roberta IbbaBiochemistry Department, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom.
James D Le CornuBiochemistry Department, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom.
Benoit DarlotBiochemistry Department, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom.
Mario HensenBiochemistry Department, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom.
Colette B LippBiochemistry Department, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom.
Gabriele MarcianòBiochemistry Department, University of Oxford, Oxford, United Kingdom.
Snežana VasiljevićBiochemistry Department, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom.
Nicole ZitzmannBiochemistry Department, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom.
Pietro RoversiIBBA-CNR Unit of Milano, Institute of Agricultural Biology and Biotechnology, Milano, Italy.
University of Oxford · GBDeleted InstitutionUniversity of Edinburgh · GBUniversity of Sassari · IT

Funding

Medical Research Council MC_PC_16056Wellcome Trust
6 · The paper itself

Abstract

None of the current data processing pipelines for X-ray crystallography fragment-based lead discovery (FBLD) consults all the information available when deciding on the lattice and symmetry (i.e., the polymorph) of each soaked crystal. Often, X-ray crystallography FBLD pipelines either choose the polymorph based on cell volume and point-group symmetry of the X-ray diffraction data or leave polymorph attribution to manual intervention on the part of the user. Thus, when the FBLD crystals belong to more than one crystal polymorph, the discovery pipeline can be plagued by space group ambiguity, especially if the polymorphs at hand are variations of the same lattice and, therefore, difficult to tell apart from their morphology and/or their apparent crystal lattices and point groups. In the course of a fragment-based lead discovery effort aimed at finding ligands of the catalytic domain of UDP-glucose glycoprotein glucosyltransferase (UGGT), we encountered a mixture of trigonal crystals and pseudotrigonal triclinic crystals-with the two lattices closely related. In order to resolve that polymorphism ambiguity, we have written and described here a series of Unix shell scripts called

Indexed as

crystal polymorphism[(morpholin-4yl)methyl]quinolin-8-olstructure-based lead discoverystructure determination pipelineUGGT

Identifiers

PMID36589243
PMCPMC9794592
OpenAlexW4311325293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.